Every fortnight another Asian founder asks us the same opening question: is Nasdaq still the right listing venue in 2026? The answer is yes, more clearly than at any point in the last decade, but only for founders who understand which of Nasdaq's three tiers to target, which of the 2026 rule changes cut in their favour, and which pathways sound available but are not. This is our standing guide to the corridor.
TL;DR
- Nasdaq has three market tiers — Global Select, Global Market, Capital Market — each with its own 2026 numerical thresholds.
- The SEC's new USD 25 million public-float minimum for China-based IPOs sharpens the filter but does not close the door.
- Nasdaq's 2026 continued-listing rules are meaningfully tighter than the entry rules. The exit floor is rising.
- The SGX-Nasdaq Global Listing Board dual-listing framework is real but built for SGD 2 billion (roughly USD 1.5 billion) market caps.
- For most mid-market Asian founders in the USD 30–500 million revenue range, the direct Nasdaq Capital Market or Global Market pathway remains the default.
Robinhood Ventures publishes fortnightly analysis on the Asia-to-Nasdaq listing corridor. This page pulls together our current thinking as a single reference for founders and their CFOs. Deeper reads are linked throughout — each linked article is authored by one of our specialists.
Nasdaq is three markets, not one.
Every founder we meet talks about "listing on Nasdaq" as if it were a single venue. It is not. Nasdaq operates three distinct market tiers, each with its own listing standards and its own investor base. The tier a company enters at listing is one of the most consequential choices in the whole 18-month pathway, because moving between tiers post-listing requires meeting the target tier's standards.
Nasdaq Capital Market is the entry tier. It exists for growth companies that meet the Nasdaq disclosure and governance bar but are still building scale. The 2026 thresholds under the equity standard are the lowest: USD 5 million in stockholders' equity, USD 15 million public float (with the China-based issuer floor raising this effectively to USD 25 million), and 300 round-lot holders. Continued-listing standards are the least demanding but not lenient.
Nasdaq Global Market sits in the middle. The equity standard requires USD 8 million in stockholders' equity and USD 5 million public float. This tier is where many Asian growth companies land at listing if they meet the numerical bar, and it carries meaningfully more prestige with institutional allocators than Capital Market.
Nasdaq Global Select Market is the top tier. It targets large, mature issuers — aggregate pre-tax income of USD 11 million across three years under the earnings standard, or USD 550 million market cap plus USD 110 million revenue under the market-cap standard. Global Select carries the highest visibility, the deepest index inclusion, and the strictest continued-listing rules.
The tier is a listing standard, not a trading venue. All three trade on identical Nasdaq technology, market makers, and rules. Where you list signals what stage of the market you are targeting.
For a full breakdown of the current thresholds by standard and tier, see Nasdaq Listing Standards 2026 by Cynthia Ng.
Three rule shifts, three different signals.
The 2026 rule changes at Nasdaq and the SEC are the most consequential in a decade. Read as a bundle, they look forbidding. Read individually, they are three different signals aimed at three different populations of issuer.
The SEC's USD 25 million floor on China-based IPOs. Introduced in early 2026, this is the headline change and the most widely misunderstood. It applies specifically to public float on IPO for issuers with meaningful China-based operations or leadership. Read as a wall, it looks like a closed door. Read as a filter, it sorts the corridor for exactly the discipline Robinhood underwrites for: cap table cleanliness, VIE-structure transparency, and PCAOB audit access. See Nasdaq's $25 Million Floor, and Who It Really Sorts For by William Du.
Tightened continued-listing rules. Nasdaq's 2026 amendments to its continued-listing standards raise the bar for staying on the exchange after IPO. The reverse-split escape hatch — long used by struggling issuers to maintain the USD 1 minimum bid price — is closing. Bid-price cures are now stricter, and repeat non-compliance triggers delisting faster. This is the quieter, more consequential shift of the year. See Nasdaq Is Closing the Exits, Not the Entrance by William Du.
The SGX-Nasdaq Global Listing Board. Launched mid-2026, this dual-listing framework lets qualifying companies trade simultaneously on both exchanges using a single prospectus. Regulatory cooperation between MAS, SGX RegCo, and the SEC is genuine. Disclosure is harmonised. Trading halts synchronise. But the eligibility threshold is high: SGD 2 billion (roughly USD 1.5 billion) minimum market cap, and the company must already be listed on the Nasdaq Global Select Market. See The Singapore-Nasdaq Bridge Is Open. Here Is Who It Actually Serves. by Cynthia Ng.
The question before the question.
Before a founder should be spending six-figure sums preparing for a Nasdaq listing, they should be sure Nasdaq is the right venue at all. The default assumption — that a US listing is always the strongest outcome — is wrong for a meaningful share of the founders we meet. Home-market listings on Bursa Malaysia, HKEX, or SGX Mainboard remain the right answer when comparable coverage, natural investor base, or currency alignment favour the home market.
We work through the decision in three lenses: capital, comparable, control. See Bursa or Nasdaq: A Three-Lens Framework by Amanda Ooi for the full framework.
Diagnostic, structuring, filing, listing.
Once the decision to list on Nasdaq is made, the engagement runs approximately 18 months from first meeting to bell-ringing. That number is not a target; it is what the sequence actually requires when done properly. Compressing it is possible in narrow circumstances but rarely advisable, because the shortcuts almost always come out of the diagnostic phase and the diagnostic phase is where the most valuable work happens.
Four phases: Diagnostic (months 1-3), Structuring and PCAOB audit (months 4-9), SEC filing and review (months 10-15), Listing and post-IPO discipline (months 16-18). See The 18-Month Listing Shape by Amanda Ooi.
The diagnostic phase runs against five questions we ask every founder before we underwrite: cap table, PCAOB audit, incorporation and IP, board reality, listing intent. See The Corporate Doctor Diagnostic: Five Questions by Cynthia Ng.
Listing is not the end. The first four quarters as a listed issuer require a governance and disclosure discipline that many founders underestimate. See Post-IPO Governance Playbook by Cynthia Ng.
What founders actually ask.
What is the minimum market cap to list on Nasdaq in 2026?
Nasdaq has three tiers. Nasdaq Capital Market requires a minimum public float of USD 15 million and shareholders' equity of USD 5 million (under the equity standard). Nasdaq Global Market requires USD 8 million in stockholders' equity plus USD 5 million public float. Nasdaq Global Select Market requires either aggregate pre-tax income of USD 11 million over three years, or USD 550 million in market cap and USD 110 million in revenue. Most mid-market Asian founders target the Capital Market or Global Market tier at listing and graduate to Global Select over time.
Can China-based companies still list on Nasdaq in 2026?
Yes. The SEC introduced a USD 25 million public float minimum for China-based IPOs in early 2026, but the pathway remains open. The floor filters for discipline, not eligibility. Companies that meet the tightened disclosure requirements around VIE structures, PCAOB audit access, and beneficial ownership continue to complete Nasdaq listings.
What is the difference between Nasdaq Global Select, Global Market, and Capital Market?
The three tiers differ in size and disclosure thresholds. Global Select is the most demanding tier, designed for large, mature issuers. Global Market sits in the middle. Capital Market is the entry tier for growth companies, with the lowest numerical thresholds but the same continued-listing discipline. All three trade on Nasdaq with identical technology, market makers, and trading rules — the tier is a listing standard, not a trading venue.
How long does it take to list on Nasdaq from Asia?
A well-run engagement takes approximately 18 months from decision to bell. That covers four phases: Diagnostic (months 1-3), Structuring and PCAOB audit (months 4-9), SEC filing and review (months 10-15), and Listing plus post-IPO discipline (months 16-18). Companies that skip the diagnostic phase and go straight to filing typically take longer overall, not shorter.
Do we need PCAOB-audited financials to list on Nasdaq?
Yes. All companies listing on Nasdaq require financial statements audited by a firm registered with the Public Company Accounting Oversight Board (PCAOB). For Asian issuers this usually means transitioning from a local auditor to a PCAOB-registered firm early in the pathway, since the audit needs to cover the two or three fiscal years shown in the F-1 or S-1 filing.
What is the SGX-Nasdaq Global Listing Board and who is it for?
The SGX-Nasdaq Global Listing Board is a dual-listing framework launched in mid-2026 that lets a company simultaneously trade on both exchanges using a single prospectus. The eligibility threshold is high: minimum market cap of SGD 2 billion (approximately USD 1.5 billion), and the company must already be listed on the Nasdaq Global Select Market. For mid-market Asian founders below that threshold, the direct Nasdaq listing pathway remains the primary route.
The founders we tell to wait.
Not every founder should be in this corridor, and Robinhood declines more engagements than it accepts. Broadly, a Nasdaq listing today is the wrong answer for founders who lack a PCAOB-auditable finance function, who are still pre-revenue or under USD 5 million ARR without a clear path to scale, or whose cap table has structural issues that would take a year to unwind before filing. It is also the wrong answer for founders whose comparable investor base sits primarily in Malaysia, Singapore, or Hong Kong and would be better served by a home-market listing.
Where we advise waiting, we usually mean 18 to 30 months: enough time to complete a PCAOB audit history, clean the cap table, install the corporate governance and finance function a Nasdaq issuer requires, and reach scale that supports a credible float. That is not a rejection. It is the diagnostic phase applied honestly.
Read the full analysis.
Each of the pieces below is a specialist deep-dive by one of our team. If you have found this guide useful, these are the underlying sources.
When you are actually ready.
Robinhood Ventures commits its own capital first, then activates corporate execution. If you are exploring a Nasdaq listing and the picture above matches yours, the corporate engagement page walks through what working together looks like: the diagnostic, the underwriting, the 18-month pathway, and what happens after the bell.